Fig. 1.
Correlation between rituximab serum levels at different time points and duration of B cell depletion
The duration of B-cell depletion was computed in each patient as the time between the date of the first rituximab infusion and the date of the first visit with B cells ≥10/µl. The correlation with serum levels of rituximab at the different visits was assessed by Spearman’s test.